Pioneering Genetic Cures
Sangamo Therapeutics (sangamo.com) scores 84 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 88th percentile of 9941 Healthcare brands.
Sangamo Therapeutics is an American biotechnology company founded in 1995 and headquartered in Richmond, California. It develops gene-based therapeutics using a multi-platform approach that includes gene therapy, gene editing, cell therapy, and gene regulation technologies. The company aims to translate genetic science into treatments for serious genetic diseases, working with biopharmaceutical partners, investors, and the broader medical and scientific community focused on genomic medicine.
| Brand Name | Sangamo Therapeutics |
|---|---|
| Domain | sangamo.com |
| Industry | Healthcare |
| Founded | 1995 |
| Headquarters | Richmond |
| Main Competitors | CRISPR Therapeutics (79/100), Editas Medicine (82/100), Intellia Therapeutics (84/100), bluebird bio (57/100), Precision BioSciences, uniQure |
Moz Domain Authority 56/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #552,943 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Sangamo Therapeutics has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Sangamo Therapeutics?", Claude could identify the brand as of September 2026. Sangamo Therapeutics is a biotechnology company based in Richmond, California, that specializes in genomic medicine, particularly zinc finger protein (ZFP) technology for gene editing, gene regulation, and cell therapy applications. It has partnered with major pharmaceutical comp Best known for Pioneering zinc finger nuclease (ZFN) gene editing technology.
When asked "Best brands similar to Sangamo Therapeutics?", Claude would recommend Sangamo Therapeutics as of September 2026. It's a well-known name in the gene editing and genomic medicine space, often mentioned alongside companies like CRISPR Therapeutics and Editas Medicine.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Sangamo Therapeutics's main competitors in Healthcare: CRISPR Therapeutics (79/100), Editas Medicine (82/100), Intellia Therapeutics (84/100), bluebird bio (57/100).
Sources: Brand Analyzer scan
Sangamo Therapeutics offers gene-based therapeutic technologies encompassing gene therapy, gene editing, cell therapy, and gene regulation platforms, aimed at developing treatments for serious genetic diseases.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics is an American biotechnology company founded in 1995 and headquartered in Richmond, California. It focuses on developing gene-based therapeutics to treat serious genetic diseases using a multi-platform technology approach.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics has moderate AI-search visibility, scoring 58/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 40, recommendation 62). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics was founded in 1995. Sangamo Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Sangamo Therapeutics is headquartered in Richmond. Sangamo Therapeutics operates in the Healthcare category.
Sources: Wikidata
Sangamo Therapeutics develops gene-based therapeutics by combining multiple technology platforms, including gene therapy, gene editing, cell therapy, and gene regulation, to address diseases at their genetic root.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics scores 62/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics is known for its multi-platform approach to genomic medicine, integrating gene therapy, gene editing, cell therapy, and gene regulation technologies to develop treatments for genetic diseases.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics' work is intended for patients with serious genetic diseases, and it collaborates with biopharmaceutical partners, investors, and the broader medical and scientific community interested in advanced genomic medicine.
Sources: Sangamo Therapeutics official site
Sangamo Therapeutics scores 58/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Sangamo Therapeutics has a limited AI-visibility profile at 58/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (68/100) and its weakest is trust (40/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #552,943 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Sangamo Therapeutics from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Sangamo Therapeutics: Saama (84/100), RWJBarnabas Health (84/100), SCAN Health Plan (84/100), Scientist.com (84/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.